이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Danaher 대차 대조표 상태
재무 상태 기준 확인 4/6
Danaher 의 총 주주 지분은 $53.4B 이고 총 부채는 $18.2B, 이는 부채 대 자기자본 비율을 34% 로 가져옵니다. 총자산과 총부채는 각각 $83.4B 및 $30.0B 입니다. Danaher 의 EBIT는 $5.2B 이며 이자보상배율은 -173.3 입니다. $7.0B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
34.1%
부채 비율
US$17.01b
부채
이자 보상 비율 | -520.3x |
현금 | US$2.37b |
주식 | US$49.90b |
총 부채 | US$28.65b |
총 자산 | US$78.56b |
최근 재무 상태 업데이트
Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly
Aug 28Is Danaher (NYSE:DHR) A Risky Investment?
May 21Is Danaher (NYSE:DHR) Using Too Much Debt?
Jan 12These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well
Jul 13Recent updates
Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?
Sep 28Danaher Q3 Preview: Market Share Gains In Molecular Testing
Sep 25Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?
Sep 12Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly
Aug 28Danaher: Lofty Price, Bright Future
Aug 22Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings
Aug 13Danaher: Valuation Now Too High Even Compared To Own High Standards
Jul 16What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?
Jun 23Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum
Jun 20Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?
Jun 05Is Danaher (NYSE:DHR) A Risky Investment?
May 21It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year
May 01Value Vs. Growth? Danaher Says Why Not Both?
Apr 25Danaher: All In On Life Sciences, And Market Update
Mar 27Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?
Mar 11Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings
Feb 10Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term
Jan 30Is Danaher (NYSE:DHR) Using Too Much Debt?
Jan 12My Top 2024 Stock Pick: Danaher
Dec 27Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles
Nov 26RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing
Nov 19Why Danaher Is One Of My Favorite Long-Term Investments
Oct 26Danaher: Short-Term Headwinds, But Long-Term Tailwinds
Oct 17Should Danaher Investors Sell New Veralto Shares?
Oct 02Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price
Sep 30Danaher: A Lost Year
Aug 30Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens
Aug 02Danaher: A Compounding Icon At A Fair Price
Jul 25These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well
Jul 13Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Jun 28Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump
Jun 22At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?
Jun 15Danaher: A Great Chance To Buy This Long-Term Compounder
May 23With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case
Apr 26Estimating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Mar 28재무 상태 분석
단기부채: DHR 의 단기 자산 ( $14.4B )이 단기 부채( $7.8B ).
장기 부채: DHR 의 단기 자산( $14.4B )은 장기 부채( $22.2B ).
부채 대 자본 내역 및 분석
부채 수준: DHR 의 순부채 대 자기자본 비율( 20.8% )은 satisfactory로 간주됩니다.
부채 감소: DHR 의 부채 대 자기자본 비율은 지난 5년간 30.1% 에서 34% 로 증가했습니다.
부채 범위: DHR 의 부채는 영업 현금 흐름 ( 38.3% )에 의해 잘 충당되었습니다.
이자 보장: DHR 지불하는 것보다 더 많은 이자를 벌기 때문에 이자 지불 보장은 문제가 되지 않습니다.